RORA and autoimmune disease: In addition, SR1001, a high-affinity ligand for RORα and RORγ, was synthesised to effectively alleviate autoimmune diseases and type 1 diabetes by targeting RORα and RORγ to restrain the function of Th17 cells [76,77].